Clinical trials
Approved for marketing Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
No trials to chart.
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Approved for marketing | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 2 |
| Astellas Pharma Global Development, Inc. | 1 |
| AstraZeneca | 1 |
| BTG International Inc. | 1 |
| Day One Biopharmaceuticals, Inc. | 1 |
| Servier | 1 |
| University of California, San Francisco | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 8 |
| Glioma | 2 |
| Recurrence | 2 |
| Astrocytoma | 1 |
| Carcinoma, Ovarian Epithelial | 1 |
| Disease Attributes | 1 |
| Leukemia | 1 |
| Lymphoma | 1 |
| Neoplasm Metastasis | 1 |
| Neoplasms by Histologic Type | 1 |
Trials
Showing 51 to 8 of 8. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.